These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25899758)

  • 1. Pathways in the diagnosis and management of diabetic polyneuropathy.
    Kaku M; Vinik A; Simpson DM
    Curr Diab Rep; 2015 Jun; 15(6):609. PubMed ID: 25899758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Tools, Biomarkers, and Treatments in Diabetic polyneuropathy and Cardiovascular Autonomic Neuropathy.
    Bönhof GJ; Herder C; Ziegler D
    Curr Diabetes Rev; 2022; 18(5):e120421192781. PubMed ID: 33845748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whither pathogenetic treatments for diabetic polyneuropathy?
    Boulton AJ; Kempler P; Ametov A; Ziegler D
    Diabetes Metab Res Rev; 2013 Jul; 29(5):327-33. PubMed ID: 23381942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetic neuropathy: an update].
    Andrade Lopes S; Fayolle D; Jornayvaz FR
    Rev Med Suisse; 2022 Jun; 18(784):1106-1109. PubMed ID: 35647748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
    Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
    Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distal sensory polyneuropathy in the context of HIV/AIDS.
    Nicholas PK; Mauceri L; Slate Ciampa A; Corless IB; Raymond N; Barry DJ; Viamonte Ros A
    J Assoc Nurses AIDS Care; 2007; 18(4):32-40. PubMed ID: 17662922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations.
    Ziegler D; Tesfaye S; Spallone V; Gurieva I; Al Kaabi J; Mankovsky B; Martinka E; Radulian G; Nguyen KT; Stirban AO; Tankova T; Varkonyi T; Freeman R; Kempler P; Boulton AJ
    Diabetes Res Clin Pract; 2022 Apr; 186():109063. PubMed ID: 34547367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study).
    Ziegler D; Landgraf R; Lobmann R; Reiners K; Rett K; Schnell O; Strom A
    Diabetes Res Clin Pract; 2018 May; 139():147-154. PubMed ID: 29518491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetic polyneuropathy].
    Ziegler D
    Internist (Berl); 2020 Mar; 61(3):243-253. PubMed ID: 32086529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity.
    Dyck PJ; Albers JW; Andersen H; Arezzo JC; Biessels GJ; Bril V; Feldman EL; Litchy WJ; O'Brien PC; Russell JW;
    Diabetes Metab Res Rev; 2011 Oct; 27(7):620-8. PubMed ID: 21695763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brief overview of the diabetic neuropathies.
    Boulton AJM
    Diabetes Res Clin Pract; 2023 Dec; 206 Suppl 1():110758. PubMed ID: 38245328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts in the management of diabetic polyneuropathy.
    Ziegler D
    Curr Diabetes Rev; 2011 May; 7(3):208-20. PubMed ID: 21534920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum bilirubin levels contribute to the presence and progression of distal symmetrical polyneuropathy in Chinese patients with type 2 diabetes.
    Jin J; Wang W; Gu T; Chen C; Sun J; Chen W; Bi Y; Zhu D
    Diabetes Metab; 2019 Jan; 45(1):47-52. PubMed ID: 29555465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts in the management of diabetic polyneuropathy.
    Ziegler D; Papanas N; Schnell O; Nguyen BDT; Nguyen KT; Kulkantrakorn K; Deerochanawong C
    J Diabetes Investig; 2021 Apr; 12(4):464-475. PubMed ID: 32918837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review.
    Galosi E; Hu X; Michael N; Nyengaard JR; Truini A; Karlsson P
    Acta Diabetol; 2022 Jan; 59(1):1-19. PubMed ID: 34213655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy (DSPN).
    Sharma S; Rayman G
    Front Endocrinol (Lausanne); 2023; 14():1165505. PubMed ID: 37274325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
    Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
    Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening tests for distal symmetrical polyneuropathy in Latin American patients with type 2 diabetes mellitus.
    Gómez-Banoy N; Cuevas V; Soler F; Pineda MF; Mockus I
    Arch Endocrinol Metab; 2017; 61(5):470-475. PubMed ID: 28724059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic Neuropathy.
    Zakin E; Abrams R; Simpson DM
    Semin Neurol; 2019 Oct; 39(5):560-569. PubMed ID: 31639839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for diabetic polyneuropathy treatment.
    Basić-Kes V; Zavoreo I; Rotim K; Bornstein N; Rundek T; Demarin V
    Acta Clin Croat; 2011 Jun; 50(2):289-302. PubMed ID: 22263398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.